Form 4: Artiva CFO's Stock Withholding for Tax Obligations

Artiva Biotherapeutics' Chief Financial Officer, Neha Krishnamohan, reported the withholding of 3,490 common shares to cover tax obligations related to restricted stock unit vesting.

Summary

• Neha Krishnamohan, Chief Financial Officer of Artiva Biotherapeutics, Inc. (ARTV), reported a transaction on November 15, 2025.
• The transaction involved the disposition of 3,490 shares of common stock.
• These shares were withheld by the company to satisfy income tax obligations arising from the vesting of restricted stock unit awards.
• The deemed price for the disposition was $3.25 per share.
• Following this transaction, Ms. Krishnamohan directly beneficially owns 99,356 shares of Artiva Biotherapeutics common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the withholding of shares for tax purposes, which is a neutral event and does not indicate any significant positive or negative sentiment regarding the company's performance or outlook.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine, non-discretionary transaction related to executive compensation and tax obligations.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary transaction where shares were withheld to cover tax obligations related to restricted stock unit vesting. Such transactions are common for executives and do not typically reflect a change in the company's fundamentals or the officer's confidence. Therefore, it provides no new information to alter an existing investment thesis, warranting a 'hold' recommendation based solely on this filing.

Keywords

Artiva Biotherapeutics, ARTV, Neha Krishnamohan, Form 4, SEC Filing, Insider Transaction, Stock Withholding, Restricted Stock Units, Tax Obligations, CFO